HKD48.20
0.21% today
Hong Kong, Jul 22, 07:15 am CET
ISIN
KYG5074A1004
Symbol
6618
Index

JD Health International Stock price

HKD48.30
+8.60 21.66% 1M
+18.00 59.41% 6M
+20.20 71.89% YTD
+27.20 128.91% 1Y
-14.90 23.58% 3Y
-61.70 56.09% 5Y
-61.70 56.09% 10Y
-61.70 56.09% 20Y
Hong Kong, Closing price Mon, Jul 21 2025
+0.60 1.26%
ISIN
KYG5074A1004
Symbol
6618
Index
Sector

Key metrics

Basic
Market capitalization
HKD152.6b
Enterprise Value
HKD96.9b
Net debt
positive
Cash
HKD56.0b
Shares outstanding
3.2b
Valuation (TTM | estimate)
P/E
33.1 | 30.3
P/S
2.4 | 2.1
EV/Sales
1.5 | 1.3
EV/FCF
20.7
P/B
2.5
Financial Health
Equity Ratio
77.5%
Return on Equity
7.5%
ROCE
5.8%
ROIC
56.1%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
HKD63.6b | HKD73.9b
EBITDA
- | HKD3.1b
EBIT
HKD3.6b | HKD2.6b
Net Income
HKD4.6b | HKD5.0b
Free Cash Flow
HKD4.7b
Growth (TTM | estimate)
Revenue
8.7% | 16.3%
EBITDA
- | -18.5%
EBIT
262.9% | -27.0%
Net Income
94.3% | 10.6%
Free Cash Flow
-5.5%
Margin (TTM | estimate)
Gross
22.9%
EBITDA
- | 4.2%
EBIT
5.6%
Net
7.2% | 6.8%
Free Cash Flow
7.4%
More
EPS
HKD1.4
FCF per Share
HKD1.5
Short interest
-
Employees
3k
Rev per Employee
HKD20.0m
Show more

Is JD Health International a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,010 stocks worldwide.

JD Health International Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a JD Health International forecast:

17x Buy
74%
5x Hold
22%
1x Sell
4%

Analyst Opinions

23 Analysts have issued a JD Health International forecast:

Buy
74%
Hold
22%
Sell
4%

Financial data from JD Health International

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
63,620 63,620
9% 9%
100%
- Direct Costs 49,062 49,062
8% 8%
77%
14,558 14,558
12% 12%
23%
- Selling and Administrative Expenses 11,485 11,485
6% 6%
18%
- Research and Development Expense 1,455 1,455
8% 8%
2%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 3,550 3,550
263% 263%
6%
Net Profit 4,553 4,553
94% 94%
7%

In millions HKD.

Don't miss a Thing! We will send you all news about JD Health International directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

JD Health International, Inc. operates as an online healthcare platform and retail pharmacy company. Its technology-driven platform is cantered on the supply chain of pharmaceutical and healthcare products and healthcare services, encompassing a user’s full life span for all healthcare needs. The firm's retail pharmacy business operates through three models: direct sales, online marketplace and Omni channel initiative. It offers comprehensive online healthcare services, such as online consultation and prescription renewal, chronic disease management, family doctor and consumer healthcare. Its platform allows doctors to practice multisite, acquire and manage targeted patients, conduct healthcare research, exchange academic and clinical knowledge and improve diagnostic and treatment skills. The company was founded on November 30, 2018 and is headquartered in Beijing, China.

Head office Cayman Islands
CEO En Jin
Employees 3,177
Founded 2018
Website ir.jdhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today